SCHEMBL3759201

SCHEMBL3759201

CC1(C)CC(=O)c2sc(N3CCOCC3)c(-c3ccnc(-c4ccc(O)cc4)c3)c2C1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 7/20 0.39
PIK3CA P42336 7/20 0.39
PIK3CG P48736 7/20 0.39
PIK3CB P42338 6/20 0.39
BUB1 O43683 1/20 0.37
GABRA1 P14867 3/20 0.36
GABRG2 P18507 3/20 0.36
GABRB3 P28472 3/20 0.36
GABRA5 P31644 3/20 0.36
GABRA3 P34903 3/20 0.36
GABRA2 P47869 3/20 0.36
PRKDC P78527 1/20 0.34
BRD4 O60885 1/20 0.34
MAP3K11 Q16584 1/20 0.34
GRIA1 P42261 2/20 0.33
NPSR1 Q6W5P4 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPKAPK2 P49137 1/20 0.33
LRRK2 Q5S007 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3758765 0.92 PIK3CA (0.40) PIK3CDPIK3CAPIK3CGPIK3CBBUB1
SCHEMBL3759257 0.91 PIK3CA (0.40) PIK3CDPIK3CAPIK3CGPIK3CBBUB1
SCHEMBL3762353 0.91 PIK3CD (0.39) PIK3CDPIK3CAPIK3CGPIK3CBBUB1
SCHEMBL3764482 0.91 BUB1 (0.44) PIK3CDPIK3CAPIK3CGPIK3CBBUB1
SCHEMBL3760904 0.91 ABL1 (0.39) PIK3CDPIK3CAPIK3CGPIK3CBBUB1
SCHEMBL3760222 0.91 PIK3CA (0.45) PIK3CDPIK3CAPIK3CGPIK3CBBUB1
SCHEMBL16161825 0.90 JAK2 (0.41) PIK3CDPIK3CAPIK3CGPIK3CBBUB1
SCHEMBL16161713 0.90 PIK3CD (0.38) PIK3CDPIK3CAPIK3CGPIK3CBBUB1
SCHEMBL3760346 0.90 PRKDC (0.41) PIK3CDPIK3CAPIK3CGPIK3CBBUB1
SCHEMBL3757659 0.89 PRKDC (0.40) PIK3CDPIK3CAPIK3CGPIK3CBBUB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA PIK3CD 9/4885PIK3CA 3/4885PIK3CG 12/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.